EPA World Congress 2022
March 22-24, 2022, Amsterdam
We are thrilled to sponsor and attend World EPA Congress 2022, Europe’s Leading Pricing, Market Access and Evidence Congress for the Biopharma Industry.
The event will feature 250 speakers, multiple streams, and over 1000 attendees from pharma, biotech, and Payers/HTA’s. The 2022 edition will now take place over three days with expanded content on RWE, HTA, Medical Devices, Affordability, Digital Health, Analytics and Emerging Markets. The event’s core topic areas will include Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence and will cover the latest trends in reimbursement, payment models, affordability, HEOR, and many other developments within the industry.
As part of the event, our very own Andrea Mantovani, Vice President, Global Market Access will also host a roundtable “Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective”.
- Andrea Mantovani, Vice President, Global Market Access
- Ahmad Bechara, Vice President Global Market Access
- Catia Proenca, Director, Market Access
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
Pharmaceutical Market Access in the UK: A Changing Landscape
Lifecycle Optimization: The Path to Commercial Success
Alira Health Joins EMIG to Advance Market Access in the UK
The State of Market Access in Italy 2023
World EPA Congress 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Subscribe to our newsletter for the latest news, events, and thought leadership